Dual dose of the Pfizer COVID-19 vaccine elicits strong antibody immune responses in older people 1st April 2021
Prior SARS-CoV-2 infection primes the immune response to one dose of Pfizer/BioNTech vaccine 26th March 2021
Published: Cellular immunity to SARS-CoV-2 found at six months in non-hospitalised individuals 8th March 2021
Antibodies generated following SARS-CoV-2 infection in spring 2020 likely able to neutralise the B.1.1.7 variant 6th March 2021